Search Results - "Merritt, William"

Refine Results
  1. 1

    Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs by Rollison, Dana E., Howlader, Nadia, Smith, Martyn T., Strom, Sara S., Merritt, William D., Ries, Lynn A., Edwards, Brenda K., List, Alan F.

    Published in Blood (01-07-2008)
    “…Reporting of myelodysplastic syndromes (MDSs) and chronic myeloproliferative disorders (CMDs) to population-based cancer registries in the United States was…”
    Get full text
    Journal Article
  2. 2

    Application of nondestructive mechanical characterization testing for creating in vitro vessel models with material properties similar to human neurovasculature by Norris, Nicholas G., Merritt, William C., Becker, Timothy A.

    “…Vessel models are a first step in developing endovascular medical devices. However, these models, often made from glass or silicone, do not accurately…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Meta-Analysis on the Effect of Pasireotide for Prevention of Postoperative Pancreatic Fistula by Dalton, Elissa C, Johns, Michael S, Rhodes, Lori, Merritt, 3rd, William T, Petrelli, Nicholas J, Tiesi, Gregory J

    Published in The American surgeon (01-12-2020)
    “…A randomized controlled trial of routine administration of pasireotide demonstrated decreased incidence of clinically significant postoperative pancreatic…”
    Get more information
    Journal Article
  6. 6
  7. 7
  8. 8

    Mitochondrial sequence variation in African-American primary open-angle glaucoma patients by Collins, David W, Gudiseva, Harini V, Trachtman, Benjamin T, Jerrehian, Matthew, Gorry, Thomasine, Merritt, 3rd, William T, Rhodes, Allison L, Sankar, Prithvi S, Regina, Meredith, Miller-Ellis, Eydie, O'Brien, Joan M

    Published in PloS one (01-10-2013)
    “…Primary open-angle glaucoma (POAG) is a major cause of blindness and results from irreversible retinal ganglion cell damage and optic nerve degeneration. In…”
    Get full text
    Journal Article
  9. 9

    Optimizing Preoperative Blood Ordering with Data Acquired from an Anesthesia Information Management System by Frank, Steven M, Rothschild, James A, Masear, Courtney G, Rivers, Richard J, Merritt, William T, Savage, Will J, Ness, Paul M

    Published in Anesthesiology (Philadelphia) (01-06-2013)
    “…BACKGROUND:The maximum surgical blood order schedule (MSBOS) is used to determine preoperative blood orders for specific surgical procedures. Because the list…”
    Get full text
    Journal Article
  10. 10

    The Dicey Role of Dicer: Implications for RNAi Therapy by MERRITT, William M, BAR-ELI, Menashe, SOOD, Anil K

    Published in Cancer research (Chicago, Ill.) (01-04-2010)
    “…The dynamic properties of RNA interference (RNAi) in cancer biology have led investigators to pursue with significant interest its role in tumorigenesis and…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Therapeutic Efficacy of a Novel Focal Adhesion Kinase Inhibitor TAE226 in Ovarian Carcinoma by HALDER, Jyotsnabaran, LIN, Yvonne G, TARI, Ana M, BORNMANN, William, FERNANDEZ, Ariel, LOPEZ-BERESTEIN, Gabriel, SOOD, Anil K, MERRITT, William M, SPANNUTH, Whitney A, NICK, Alpa M, HONDA, Toshiyuki, KAMAT, Aparna A, HAN, Liz Y, TAE JIN KIM, CHUNHUA LU

    Published in Cancer research (Chicago, Ill.) (15-11-2007)
    “…Focal adhesion kinase (FAK) overexpression is frequently found in ovarian and other cancers and is predictive of poor clinical outcome. In the current study,…”
    Get full text
    Journal Article
  16. 16
  17. 17

    A cost analysis of sorafenib for desmoid tumors by Johns, Michael S, Merritt, William T, Rhodes, Lori, Ford, Candice N, Thompson, Mark, Lee, William M, Sheldon, Yarrow, Petrelli, Nicholas J, Tiesi, Gregory J

    Published in Journal of oncology pharmacy practice (01-04-2023)
    “…Introduction A recent randomized trial demonstrated that sorafenib improved progression free survival (PFS) in patients with desmoid tumors despite many…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Clinical and Biological Significance of Vascular Endothelial Growth Factor in Endometrial Cancer by KAMAT, Aparna A, MERRITT, William M, CHUNHUA LU, COLEMAN, Robert L, GERSHENSON, David M, SOOD, Anil K, COFFEY, Donna, LIN, Yvonne G, PATEL, Pooja R, BROADDUS, Russell, NUGENT, Elizabeth, HAN, Liz Y, LANDEN, Charles N, SPANNUTH, Whitney A

    Published in Clinical cancer research (15-12-2007)
    “…Purpose: Vascular endothelial growth factor (VEGF) is critical for angiogenesis and tumor progression; however, its role in endometrial cancer is not fully…”
    Get full text
    Journal Article
  20. 20